FDA Announces New Measures to Stem Opioid Crisis

prescription pill bottles

The U.S. Food and Drug Administration (FDA) announced this week it will take new steps to address the nation’s opioid epidemic, according to The Wall Street Journal.

The agency said it will require makers of opioid painkillers to conduct studies of the drug’s long-term effectiveness. The FDA also will require the packaging of pills in small amounts, to reduce the chance drugs will be misused or diverted for resale. The agency said it will soon announce measures to reduce the prescribing of fentanyl.

“Another critical part of our efforts for 2019 is new steps to promote the development of drugs to treat pain that are not addictive,” FDA Commissioner Scott Gottlieb said in a statement.

Earlier this month, CNN reported the FDA is weighing whether to recommend prescribing the opioid overdose antidote naloxone along with opioid prescriptions.

Heroin & the Opioid Epidemic: From Understanding to Action

Heroin and other opioids are ravaging communities across America. Heroin-related deaths increased by more than five times between 2010 and 2017, and drug deaths from fentanyl and other synthetic opioids are seeing a sharp rise as well.


Leave a Comment

Please leave a comment below to contribute to the discussion. If you have a specific question, please contact a Parent Specialist, who will provide you with one-on-one help.

Your email address will not be published. Required fields are marked *